Christopher P. Cannon, MD, is an Associate Professor of Medicine at Harvard Medical School in the Cardiovascular Division at Brigham and Women's Hospital in Boston. He is a senior investigator of the Thrombolysis in Myocardial Infarction (TIMI) Study Group, and for more than 20 years has been the principal investigator for 10 international clinical trials in the area of heart attacks and prevention.
